Drug Combination Details
| General Information of the Combination (ID: C48038) | |||||
|---|---|---|---|---|---|
| Name | Naringin NP Info | + | Trimetazidine Drug Info | ||
| Structure |
|
+ |
|
||
| Disease |
Renal failure
[ICD-11: GB60]
|
Investigative | [1] | ||
| Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
|---|---|---|---|---|---|---|
| α. Enhancing Drug Efficacy by This Combination | ||||||
| Achieving Therapeutic Synergy | Click to Show/Hide | |||||
| Experiment 1 Reporting the Effect of This Combination | [1] | |||||
| In-vivo Model | Forty male Sprague-Dawley rats weighting ranged from 200 to 250 g were used in this study. | |||||
| Experimental
Result(s) |
NAR, TMZ, or their combination could attenuate the Nrf-2 expression in the kidney tissue, following the renal IR injury through inhibition of lipid peroxidase, and enhancement of antioxidant activity. | |||||